Loss of beta-cell identity and function as a mechanism of secondary failure of sulfonylurea therapy in diabetes

Authors

• Sumit Patel, Washington University School of Medicine in St. Louis
• Zihan Yan, Washington University School of Medicine in St. Louis
• Maria S Remedi, Washington University School of Medicine in St. Louis

Journal

MedComm

Publication Date

2-1-2026

Volume

7

Issue

2

First Page

e70588

Document Type

Open Access Publication

DOI

10.1002/mco2.70588

Rights and Permissions

S. Patel, Z. Yan, and M. S. Remedi, “ Loss of Beta-Cell Identity and Function as a Mechanism of Secondary Failure of Sulfonylurea Therapy in Diabetes.” MedComm 7, no. 2 (2026): e70588. https://doi.org/10.1002/mco2.70588 © 2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Patel, Sumit; Yan, Zihan; and Remedi, Maria S, "Loss of beta-cell identity and function as a mechanism of secondary failure of sulfonylurea therapy in diabetes." MedComm. 7, 2. e70588 (2026).
https://digitalcommons.wustl.edu/oa_4/7267

Additional Links

Supplemental material is available for this article at publisher site.